ASCO Optimum Imaging Strategies for Advanced Prostate Cancer Guidelines Pocket Guide Cover

Optimum Imaging Strategies for Advanced Prostate Cancer GUIDELINES Pocket Guide

Approved By

American Society of Clinical Oncology

Digital Subscription $0.00 Add to Library
Print $9.95 Add to Cart
Free Sample

Access to this digital pocket guide is provided at no cost, compliments of Blue Earth Diagnostics, Inc. To access click the “Add to My Library” button above, or CLICK HERE

The digital version of the American Society of Clinical Oncology Optimum Imaging Strategies for Advanced Prostate Cancer GUIDELINES Pocket Guide contains all the same great information found in the pocket guide, and can be accessed on mobile devices and online:

  • For a single low price: FREE, compliments of Blue Earth Diagnostics, Inc.
  • Supported platforms
    • iPhone and iPad
    • Android phones and tablets
    • Online (internet connection required)
  • To access offline within our mobile app you must click the “add to my library” button above

For mobile access, download the free app from the App Store or Google Play and use the same email address and password as the website to login.

The Optimum Imaging Strategies for Advanced Prostate Cancer Pocket Guide is based on the latest guidelines of the American Society of Clinical Oncology and was developed with their collaboration. It contains graded recommendations for imaging in advanced prostate cancer including two management algorithms.

  • Multifold
  • 8 Pages
  • 80# Diamond Silk Cover with Satin Aqueous Coating
  • 4.25″ x 7.25″
  • Introduction
  • Treatment Recommendations
    • Newly Diagnosed Clinically High-Risk/Very High-Risk Localized Prostate Cancer
      • Conventional imaging negative
      • Conventional imaging suspicious/equivocal
      • Rising PSA after prostatectomy and negative conventional imaging (either initial PSA undetectable with subsequent rise or PSA never nadirs to undetectable)
      • Rising PSA after radiotherapy and negative conventional imaging
      • Metastatic prostate cancer at initial diagnosis or after initial treatment, hormone sensitive
      • Non-metastatic CRPC (nmCRCP)
    • Metastatic CRPC
      • PSA progression
      • Radiographic progression on conventional imaging
  • Algorithms
    • Imaging Algorithm for High/Very High-Risk Disease at Initial Ptresentation (per National Comprehensive Cancer Network [NCCN])
    • Imaging algorithm for patients with rising prostate-specific antigen (PSA) after local treatment

Founded in 1964, the American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people with cancer.

  • Guideline Pricing

  • Single Title
    $4.99 / year
  • Any 5 Titles
    $23.99 / year
  • Any 10 Titles
    $41.99 / year
  • Any 35 Titles
    $74.99 / year
  • All Available Titles
    $169.99 / year

To get started, log in or create your free account Create Account